Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Therapeutic Strategies for Diabetes in Pregnancy"
Deadline for manuscript submissions: closed (10 April 2018).
Interests: Diabetes in pregnancy, including type 1 and type 2 diabetes in pregnancy, and gestational diabetes. I am particularly interested in the association between maternal glycaemic variability and foetal overgrowth.
Hyperglycaemia in pregnancy, comprising pre-existing type 1 or type 2 diabetes in pregnancy and gestational diabetes, is rising in incidence and is associated with an increased likelihood of adverse perinatal outcomes. Women with diabetes in pregnancy are at greater risk of pre-term delivery, complications in delivery and unplanned caesarean sections, and poor neonatal outcomes, such as macrosomia, birth injuries and hypoglycaemia. Furthermore, in utero exposure to hyperglycaemia can lead to a predisposition towards obesity and chronic disease in adult life.
The management of diabetes in pregnancy comprises a multi-disciplinary approach, wherein diabetes educators, dieticians, midwives, obstetricians and endocrinologists play a pivotal role. However, due to a combination of factors including more stringent diagnostic criteria and higher rates of risk factors for gestational diabetes in women of reproductive age, there is an increasing strain on the healthcare system to provide care to women with diabetes in pregnancy. Thus, it is of significant clinical importance that new therapeutic strategies are devised, such that optimal care is provided to pregnant women with diabetes and better perinatal outcomes can be achieved.
The care of both pre-existing diabetes in pregnancy and gestational diabetes overlap and span the entire prenatal and antenatal period. Pre-pregnancy optimisation of glycaemic control is fundamental to avoiding the risk of congenital anomalies in women with type 1 and type 2 diabetes; likewise, maintaining a body weight and BMI in the healthy range is important for all women entering pregnancy. Achieving target blood glucose levels and minimising glycaemic excursions through frequent blood glucose monitoring, appropriate dietary changes and use of anti-hyperglycaemic medications, such as metformin and insulin, are also central features of diabetes in pregnancy management. Furthermore, early identification of women at increased risk of gestational diabetes as well as those with unrecognised diabetes in pregnancy, such that education and intervention can be provided, contribute towards minimisation of pregnancy complications and improved outcomes for both mother and neonate.
This Special Issue of the Journal of Clinical Medicine will detail the most recent advances in therapies for diabetes in pregnancy, as well as provide an up-to-date overview of strategies that can be employed to ensure this population of women with high-risk pregnancies, and their neonates, have the best outcomes.
Dr. Rachel McGrath
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- gestational diabetes
- pre-existing diabetes in pregnancy
- glycemic control
- perinatal outcomes
- antenatal diabetes care
- birth weight